Retirement Systems of Alabama raised its stake in shares of Sotera Health (NASDAQ:SHC – Free Report) by 20.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 185,779 shares of the company’s stock after purchasing an additional 32,051 shares during the quarter. Retirement Systems of Alabama’s holdings in Sotera Health were worth $3,103,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. William Blair Investment Management LLC boosted its stake in Sotera Health by 0.6% during the 2nd quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company’s stock valued at $13,430,000 after purchasing an additional 6,707 shares during the period. Clearline Capital LP bought a new stake in shares of Sotera Health in the second quarter valued at approximately $1,707,000. Maven Securities LTD bought a new stake in shares of Sotera Health in the third quarter valued at approximately $1,670,000. Darsana Capital Partners LP acquired a new stake in shares of Sotera Health in the second quarter worth $29,074,000. Finally, First Pacific Advisors LP bought a new position in Sotera Health during the second quarter worth $540,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.
Sotera Health Stock Down 0.2 %
Shares of SHC opened at $13.24 on Friday. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The company has a 50-day moving average price of $14.39 and a two-hundred day moving average price of $14.21. The stock has a market cap of $3.75 billion, a price-to-earnings ratio of 52.96 and a beta of 1.96. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44.
Analysts Set New Price Targets
Several research firms have issued reports on SHC. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target on the stock. Citigroup lifted their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a report on Thursday, November 21st. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $16.08.
Get Our Latest Research Report on Sotera Health
Sotera Health Profile
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Stories
- Five stocks we like better than Sotera Health
- Stock Analyst Ratings and Canadian Analyst Ratings
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What Are Dividend Achievers? An Introduction
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What Are Trending Stocks? Trending Stocks Explained
- 2 Underrated Quantum Computing Companies Starting to Rally
Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health (NASDAQ:SHC – Free Report).
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.